Search results
Results From The WOW.Com Content Network
The Bureau of Narcotics and Dangerous Drugs (BNDD) was a federal law enforcement agency within the United States Department of Justice with the enumerated power of investigating the consumption, trafficking, and distribution of narcotics and dangerous drugs.
A DEA number (DEA Registration Number) is an identifier assigned to a health care provider (such as a physician, physician assistant, nurse practitioner, optometrist, podiatrist, dentist, or veterinarian) by the United States Drug Enforcement Administration allowing them to write prescriptions for controlled substances.
The Drug Enforcement Administration was established on July 1, 1973, [4] by Reorganization Plan No. 2 of 1973, signed by President Richard Nixon on July 28. [5] It proposed the creation of a single federal agency to enforce the federal drug laws as well as consolidate and coordinate the government's drug control activities.
The United States Drug Enforcement Administration (DEA) maintains lists regarding the classification of illicit drugs (see DEA Schedules).It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs.
McVeigh's criterion for attack sites was that the target should house at least two of three federal law enforcement agencies: the Bureau of Alcohol, Tobacco, and Firearms (ATF), the Federal Bureau of Investigation (FBI), and the Drug Enforcement Administration (DEA).
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The FBN was established on June 14, 1930, consolidating the functions of the Federal Narcotics Control Board and the Bureau of Prohibition (BOI) Narcotic Division. [4] These preceding bureaus were established to assume enforcement responsibilities assigned to the Harrison Narcotics Tax Act of 1914 and the Jones–Miller Narcotic Drugs Import and Export Act of 1922.
Under the Controlled Substances Act, dihydromorphine is listed as a Schedule I substance along with heroin. [13] In the United States, its role in the production of dihydrocodeine and other related drugs make it a Schedule I substance with one of the higher annual manufacturing quotas granted by the US Drug Enforcement Administration: 3300 kilograms in 2013.